The HCPLive pain page is a resource for medical news and expert insights on pain medicine. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for acute pain, chronic pain, addiction medicine, and more.
October 4th 2024
Crisugabalin at 40 mg/d or 80 mg/d significantly reduced daily pain in adults with postherpetic neuralgia, a phase 3 study found.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Gout Drug May Prevent Kidney Damage Caused by Diabetes
September 16th 2015Gout has been making quite a stir in news recently. Between a new classification system and a study showing that a common food can cause painful flares, this form of arthritis is getting quite a bit of attention. Now comes word that a drug used to treat gout could also be effective for another damaging condition.
Medical Marijuana: $100 Mil Investment in Jamaican Weed
A Canadian company announced it would invest $100 million (US dollars) in Jamaican marijuana research and development. A Colorado company also plans to invest there. Though marijuana has long been grown in Jamaica and exported illegally, the island's government decriminalized medical use in February.
Patients with RA and No Inflammation May Experience Neuropathic Pain
Treatment advances in rheumatoid arthritis (RA), including the development and widespread deployment of disease-modifying antirheumatic drugs (DMARDs) and biologic therapies, mean that patients now often have significant periods of low disease activity. But a study in Arthritis Research & Therapy indicates that even patients reaching sustained remission report some potential neuropathic pain even when inflammation is well-controlled.
Painful Menstruation Often Ignored By Patients and Caregivers Alike
Women suffering from primary dysmenorrhea – painful menstruation in the absence of any sort of pelvic pathology – are unlikely to think much of it, chalking it up to a normal part of the menstrual cycle. A review in Human Reproduction Update, however, suggests that health professionals and pain researchers also generally ignore the condition.
Medical Marijuana: Analysis Says Not Effective for Pain, Doctor Says Prescribe Anyway
An analysis in Canadian Family Physician casts further doubt on the ability of marijuana to provide pain relief for patients with chronic noncancer pain (CNCP). Yet, in an accompanying editorial in the same issue, Roger Ladouceur, MD, Associate Scientific Editor of CFP, suggests that pain management specialists continue to prescribe it.
Headache Guidelines Short on Length, Long on Utility
A series of physician guidelines for headache care recently published in Canadian Family Physician was aimed at family physicians but has applicability for physical and occupational therapists, nurses and practitioners, physician assistants, pharmacists, and psychologists, among others. The brevity of the guidelines is among its strengths, along with the breadth of issues for which care guidelines are listed.
Does Pain Treatment Differ by Ethnicity?
Pain is pain, regardless of the race, gender, or ethnicity of the person experiencing it. But pain treatment may not be so blind. Some studies in adult patients have shown that ethnicity and race might be associated with disparities in analgesia and opioid treatment in Emergency Department (ED) patients with limb fractures. Fortunately, a study in The Annals of Emergency Medicine suggests that ethnic differences did not make a difference in pain treatment in a pediatric ED in northern Israel.
Do State-Level Opioid Control Programs Decrease Abuse and Diversion?
Like every year, PAINWeek, which kicks off this week in Las Vegas, will include dozens of presentations on abuse and diversion. It is a topic that is always front and center for pain management practitioners, and one for which there are no easy answers.
FDA Approves First 24-Hour Extended-Release Aspirin
September 9th 2015Cardiovascular patients are the focus of the recent drug approval by the Food and Drug Administration (FDA). Branded under the name Durlaza, the 24-hour extended-release aspirin is the first of its kind and is expected to become available before the end of the year.
Major Injury Risk for Rheumatoid Arthritis Patients Using DMARDs
Patients with moderate rheumatoid arthritis (RA) taking disease-modifying anti-rheumatic drugs (DMARDs) have a similar risk of joint fracture that requires surgery as RA patients with high disease activity.
New CDC Program Funds States to Help Prescription Drug Overdose Epidemic
September 8th 2015Every day 46 people in the United States die from a prescription painkiller overdose. As part of its effort to combat this startling epidemic, the Centers for Disease Control and Prevention (CDC) will soon launch a comprehensive prevention program.
Chronic Pain: Lidocaine Metabolite May Help and Open New Avenues of Treatment
Lidocaine metabolite N-ethylglycine (EG) relieves hyperalgesia and allodynia in animal models for chronic pain, suggests a study in Pain. The finding is an indicator that use of Glycine transporter 1 substrates might constitute a new drug target for the modulation of glycinergic inhibition in pain signaling.
Does Proper Placement of a TENS Device Impact Pain Threshold?
A recent study in the Journal of Pain Research found that placing an electrical stimulation device properly doesn't necessarily increase the pain threshold for health patients subjected to transcutaneous electrical nerve stimulation (TENS). The finding is important because TENS is among many nonpharmacological interventions for pain around which clinical opinion on effectiveness is split.
Treating Migraine through the Trigeminal Ganglion
Research has established that various parts of the trigeminal system are responsible for peripheral symptoms of migraine. Treatment with corticosteroids reduces the symptoms of migraine, but the treatment is associated with long-term side effects.
Gene Regulates Tissue Damage Severity in Rheumatoid Arthritis
August 31st 2015Early diagnosis continues to be one of the biggest challenges associated with rheumatoid arthritis (RA); however, researchers have identified a genetic marker that can predict tissue damage severity that could lead to better treatments.
Stress from Migraines Can Cause More Migraines
Stress resulting from frequent migraine headaches may contribute to the development of medical and psychological comorbidities that can result in an ugly cycle of more migraines, according to a study in the Journal of Pain Research.
For Patients with Chronic Pain…Blame Dad?
A Japanese study suggests that parental bonding style during childhood is associated with the prevalence of chronic pain in adults in the general population and that the association is more robust for paternal bonding than for maternal bonding.